TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

LATEST NEWS

7 Financials Stocks Oppenheimer Recommends to Buy For the Next Six Months
JIM CRAMER

Square, Manitowoc, FMC Corp: 'Mad Money' Lightning Round

PRESS RELEASES

Radius Health & Menarini Group Provide Elacestrant Update

7 Financials Stocks Oppenheimer Recommends to Buy For the Next Six Months
JIM CRAMER

Square, Manitowoc, FMC Corp: 'Mad Money' Lightning Round

Why Aren't Markets Thinking About the Risk of a Syrian Counterattack?
JIM CRAMER

Nobody Likes Tariffs: Cramer's 'Mad Money' Recap

Wall Street Isn't Euphoric ... Yet
JIM CRAMER

It's Bad, But It's Not a Crash: Cramer's 'Mad Money' Recap

Shopify Tanks After Correcting Second-Quarter Results
JIM CRAMER

Shopify, Kinder Morgan, Pfizer: 'Mad Money' Lightning Round

Mallinckrodt Spikes on Positive Regenerative Tissue Treatment Results
HEALTH

Biotech Movers: NeuroDerm Shares Soar on Sale to Japanese Firm

Mallinckrodt Spikes on Positive Regenerative Tissue Treatment Results
HEALTH

Biotech Movers: BioCryst, Omeros, Radius Health

Juno Therapeutics Stock Climbs, Wedbush Sees Advantages from Gilead, Kite Deal
STOCKS

Insiders Love Bioverativ, Juno Therapeutics and More

Stay Focused on the Green Lights: Cramer's 'Mad Money' Recap (Wed 8/30/17)
STOCKS

6 Hot Unusual Volume Charts, Radius Health and Blackstone Group Included

Jim Cramer: Radius Health Is a Takeover Target
VIDEO

Jim Cramer: Radius Health Is a Takeover Target

AveXis, Esperion and Amgen Among Biotech Movers
STOCKS

Amgen Osteoporosis Drug Approval Plan Derailed Over Heart Safety Risk -- Jim Cramer Weighs In

Amgen Cholesterol Drug Cuts Risk of Heart Attack, Stroke but Not Enough to Quell Value Debate
HEALTH

Biotech Movers: Radius Health, Amgen, Paratek

Six Flags: Cramer's Top Takeaways
JIM CRAMER

Six Flags, Cara Therapeutics, Hertz Global Holdings: 'Mad Money' Lightning Round

13 Picks to Run Donald Trump's Fed, From a 'Pharma Bro' to a Gold-Hoarding Dealmaker
JIM CRAMER

Ignore That Man in the White House? Cramer's 'Mad Money' Recap

Twitter Appoints Former Google CFO to Board of Directors
STOCKS

Insiders Are Loading Up on Twitter TWTR, Biogen BIIB & More

Herbalife Stock Falls After Chinese Exec Leaves After 10 Years
STOCKS

5 Stocks Insiders Love Right Now

'Mad Money' Lightning Round: Take Citi Over CIT Group
JIM CRAMER

'Mad Money' Lightning Round: Take Citi Over CIT Group

Jim Cramer's 'Mad Money' Recap: Here's What's Ailing This Market
JIM CRAMER

Jim Cramer's 'Mad Money' Recap: Here's What's Ailing This Market

Pardon Me, but I Have a Few Things to Say... Trump, Bernie, Radius, Ariad
STOCKS

Pardon me, but I have a few things to say... Trump, Bernie, Radius, Ariad

'Mad Money' Lightning Round: I'm Faithful to Opko Health's CEO
JIM CRAMER

'Mad Money' Lightning Round: I'm Faithful to Opko Health's CEO

Jim Cramer's 'Mad Money' Recap: Don't Play the Short-Term Market Game
JIM CRAMER

Jim Cramer's 'Mad Money' Recap: Don't Play the Short-Term Market Game

Jim Cramer's Top Takeaways: Nike, Newell Brands, Paychex, Radius Health
STOCKS

Jim Cramer's Top Takeaways: Nike, Newell Brands, Paychex, Radius Health

Jim Cramer's 'Mad Money' Recap: Don't Touch These 'Third Rail' Stocks
JIM CRAMER

Jim Cramer's 'Mad Money' Recap: Don't Touch These 'Third Rail' Stocks

PE: More a Buyer Than a Seller This Year?
MERGERS AND ACQUISITIONS

Overboarded directors at valeant, yahoo! and elsewhere struggle with activists, m&a